| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |